Fresenius Kabi is a German pharmaceutical company based in Bad Homburg, Hesse.
It is a subsidiary of Fresenius.
Fresenius Kabi is a supplier for the 0.9% Sodium Chloride Injection USP diluent for the BNT162b2 COVID-19 vaccine developed by Pfizer and BioNTech.1)